RNA Pol II–dependent transcription efficiency fine-tunes A-to-I editing levels
Genome Research · 2024
DOI: 10.1101/gr.277686.123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genome Research, 2024. Verfasst von Brigitta Szabo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Developmental Biology, Center for Anatomy and Cell Biology, Medical University of Vienna, A-1090 Vienna, Austria. Hauptthemen laut MEDLINE: RNA Polymerase II, RNA Precursors, RNA Editing. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Austrian Science Fund FWF, Austrian Science Fund Project, Collaborative Research Centre 992 Medical Epigenetics.
Abstract (Originalsprache)
A-to-I RNA editing is a widespread epitranscriptomic phenomenon leading to the conversion of adenosines to inosines, which are primarily interpreted as guanosines by cellular machines. Consequently, A-to-I editing can alter splicing or lead to recoding of transcripts. As misregulation of editing can cause a variety of human diseases, A-to-I editing requires tight regulation of the extent of deamination, particularly in protein-coding regions. The bulk of A-to-I editing occurs cotranscriptionally. Thus, we studied A-to-I editing regulation in the context of transcription and pre-mRNA processing. We show that stimulation of transcription impacts editing levels. Activation of the transcription factor MYC leads to an up-regulation of A-to-I editing, particularly in transcripts that are suppressed upon MYC activation. Moreover, low pre-mRNA synthesis rates and low pre-mRNA expression levels support high levels of editing. We also show that editing levels greatly differ between nascent pre-mRNA and mRNA in a cellular system, as well as in mouse tissues. Editing levels can increase or decrease from pre-mRNA to mRNA and can vary across editing targets and across tissues, showing that pre-mRNA processing is an important layer of editing regulation. Several lines of evidence suggest that the differences emerge during pre-mRNA splicing. Moreover, actinomycin D treatment of primary neuronal cells and editing level analysis suggests that regulation of editing levels also depends on transcription.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell and Developmental Biology, Center for Anatomy and Cell Biology, Medical University of Vienna, A-1090 Vienna, Austria.
- Department of Cell and Developmental Biology, Center for Anatomy and Cell Biology, Medical University of Vienna, A-1090 Vienna, Austria konstantin_licht@gmx.de michael.jantsch@meduniwien.ac.at.
ORCID-Profile: Konstantin Licht
Förderung
- Austrian Science Fund FWF
- Austrian Science Fund Project
- Collaborative Research Centre 992 Medical Epigenetics
- DFG
- German Federal Ministry of Education and Research
Zitieren
APA
Szabo, B., Mandl, T. C., Woldrich, B., Diensthuber, G., Martin, D., Jantsch, M. F., & Licht, K. (2024). RNA Pol II–dependent transcription efficiency fine-tunes A-to-I editing levels. Genome Research. https://doi.org/10.1101/gr.277686.123
Vancouver
Szabo B, Mandl TC, Woldrich B, Diensthuber G, Martin D, Jantsch MF, et al. RNA Pol II–dependent transcription efficiency fine-tunes A-to-I editing levels. Genome Research. 2024. doi:10.1101/gr.277686.123
BibTeX
@article{Szabo2024,
author = {Szabo, Brigitta and Mandl, Therese C and Woldrich, Bernhard and Diensthuber, Gregor and Martin, David and Jantsch, Michael F and Licht, Konstantin},
title = {RNA Pol II–dependent transcription efficiency fine-tunes A-to-I editing levels},
journal = {Genome Research},
year = {2024},
doi = {10.1101/gr.277686.123}
}
EUVIMED